Abstract
In Cancer Cell, Bolomsky etal., Duplaquet etal., and He etal. identify cancers that are dependent on the BAF chromatin remodeling complex, specifically IRF4-driven multiple myeloma and POU2F3-subtype small cell lung cancer, highlighting potential therapeutic applications for BAF complex inhibitors/degraders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have